Not provided
Not provided
Not provided
Not provided
Not provided
Several studies going on at the same time.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research is to investigate the non-opioid (non-narcotic) pain-relieving medications clonidine and gabapentin to see if they decrease the amount of opioid pain medications needed after surgery, thereby reducing opioid-related side effects, and time required to return to normal activities of daily living after surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sugar Pill | Placebo Comparator | Frequency and Dosage:
|
|
| Clonidine | Active Comparator | Dosage: 0.2 mg
|
|
| Gabapentin | Active Comparator | Dosage: 600 mg
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sugar pill | Drug | Dosage form: capsule, by mouth Dosage: not applicable Frequency and Dosage:
|
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative Pain using a Verbal Rating Scale (VRS) | Outcomes will be measured with follow up questionnaires at 1, 2, or 3, then 7 and 30 days after surgery | 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Opioid consumption obtained from the recorded data | Perioperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts) Post discharge use of opioid consumption (data obtained from the follow up questionnaires at 1, 2, or 3, then 7 and 30 days after surgery) | 1 month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ronald H Wender, MD | Cedars-Sinai Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | United States |
Not provided
| ID | Term |
|---|---|
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000073893 | Sugars |
| D000077206 | Gabapentin |
| D003000 | Clonidine |
| ID | Term |
|---|---|
| D002241 | Carbohydrates |
| D000588 | Amines |
| D009930 | Organic Chemicals |
| D005680 | gamma-Aminobutyric Acid |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Gabapentin | Drug | Dosage form: capsule, by mouth Dosage: 600 mg Frequency and duration:
|
|
|
| Clonidine | Drug | Dosage form: capsule, by mouth Dosage: 0.2 mg Frequency and duration:
|
|
|
| postoperative nausea and vomiting using a Verbal Rating Scale |
Outcomes will be measured with follow up questionnaires at 1, 2, or 3, then 7 and 30 days after surgery |
| 1 month |
| return to normal activities of daily living using follow up questionnaires | return to normal activities of daily living(including dietary intake, bowel and bladder function, physical activities) | 1 month |
| Patient satisfaction using a verbal rating scale from 0 to 100 | 0= Not satisfied 100= Excellent | 1 month |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000613 |
| Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D003509 | Cyclohexanecarboxylic Acids |
| D000146 | Acids, Carbocyclic |
| D003510 | Cyclohexanes |
| D003516 | Cycloparaffins |
| D006840 | Hydrocarbons, Alicyclic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
| D048288 | Imidazolines |
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |